Introduction. Women with epilepsy (WWE) are generally treated as a risk group during pregnancy, but over 90% of pregnant WWE have favorable pregnancies. However, the risk of some pregnancy and delivery complications may be increased among WWE, especially those on antiepileptic drugs. Material and methods. This nationwide, retrospective population-based cohort study includes WWE who gave birth in Finland during 1987-2008 (n = 1737) and the reference cohort of a random sample of women without epilepsy (n = 4357). Identification of the cohorts, and information on hospitalizations and deliveries were obtained from the Finnish Health Registers and population statistics. Multivariate analyses were conducted by binomial regression. Results. WWE were more often hospitalized during pregnancy for accidents or other external causes [adjusted risk ratio (aRR) 1.74, 95% confidence interval (CI) 0.98-3.09], premature rupture of membranes (aRR 1.75, 95% CI 1.14-2.69) and premature contractions (aRR 1.75, 95% CI 1.36-2.23). Hospitalizations for infections were more frequent in WWE (1.4% vs. 0.4%, aRR 3.15, 95% CI 1.72-5.76). The risk for induction of delivery or a cesarean section was increased in WWE. There was no difference in premature deliveries between the groups, but the risk of being small for gestational age (aRR 1.57, 95% CI 1.23-2.01), admission to neonatal intensive care unit (aRR 1.66, 95% CI 1.39-1.97), and need for respiratory care (aRR 2.37, 95% CI 1.57-3.60) was clearly increased in the offspring of WWE. Conclusions. WWE are at an increased risk of complications and hospitalizations during pregnancy and delivery. However, the majority of WWE have a normal pregnancy and delivery.
Introduction
Epilepsy affects approximately 1% of the general population (1, 2) . It is the most frequent major neurological disease in pregnancy, as 0.3-0.8% of pregnant women have epilepsy (3, 4) . Women with epilepsy (WWE) are generally treated as a risk group during pregnancy, even though over 90% of them have favorable pregnancy outcomes (2, 5) .
Mainly small, hospital-based studies on obstetric complications of WWE have been carried out, but recently some population-based studies have also been published. Some evidence suggests moderately increased rates of cesarean section (CS) and late pregnancy bleeding, as well as slightly increased rates of premature contractions, and premature delivery for WWE taking antiepileptic drugs (AED) (6, 7) . Overall, most WWE have a normal pregnancy outcome, even though increased rates of several pregnancy complications have been suggested (1) . Further research is needed to assess whether epilepsy is associated with increases in preeclampsia (6, 7) , premature delivery and placental abruption (8) .
We conducted this nationwide, population-based cohort study to obtain more accurate and generalizable estimates of pregnancy and delivery-related complication risks among WWE as well as perinatal health risks of WWE. For this purpose, we compared the occurrence of pregnancy and delivery complications, as well as obstetric outcomes of WWE with other women. Our study questions were: (1) Do the women with epilepsy have more complications during pregnancy and delivery than their references? (2) Do their offspring have more perinatal complications in relation to the reference children born to mothers without epilepsy?
Material and methods
The costs of most prescribed medicines are reimbursable for all Finnish residents through the Social Insurance Institution (SII), providing the state-maintained and taxfinanced National Health Insurance. Currently over 30 chronic diseases, including epilepsy, are covered through higher special reimbursement. To be entitled to a special reimbursement for AEDs, a medical certificate is required demonstrating that the epilepsy diagnosis is based on clinical examinations, fulfills international criteria and is made by a board-certified neurologist. The medical certificate is submitted almost always to the SII upon commencing AED treatment.
We identified women entitled to a special reimbursement for AED from the SII database and obtained the starting date of reimbursement. We did not have information on actual use of AEDs or other medications. The base cohort of WWE (n = 9124) consisted of all women born in 1920-1979 who were for the first time entitled to a special reimbursement for AEDs between 1 January 1985 and 31 December 1994 and were alive and resident in Finland on 1 January 1990. Information on a few women who died before 1 January 1990 was not available. Women who were at fertile ages (15-49 years) during follow up, and who had reimbursement for AED due to epilepsy, formed the eligible epilepsy cohort (n = 6535) ( Figure 1 ).
The base reference cohort (n = 22 362) was formed as a stratified random sample of all women alive and resident in Finland on 1 January 1990, identified from the Finnish Population Register Center with frequency-matching by five-year age group to the WWE. The eligible reference cohort was confined to fertile-aged women (n = 14 704). The mean starting date of reimbursement in the five-year age group of WWE was then used as an index date for the corresponding five-year age group of the reference cohort. Those women who gave birth after the reimbursement decision (or the corresponding index date for the reference cohort) were included in the analyses.
The information on deliveries and maternal characteristics was obtained from the Medical Birth Register (MBR) maintained by the National Institute for Health and Welfare. Information included all live-born or stillborn children (birthweight ≥500 g or gestational age ≥22 weeks). Information was also available on gestational age, number of fetuses, mode of delivery (CS or assisted delivery), induction of delivery, need for respiratory care, admission to neonatal intensive care unit, and on previous pregnancies, deliveries and stillbirths. The registered deliveries (first delivery after the reimbursement or index date) occurred between years 1987 and 2008. The final study cohort included 1737 pregnant WWE and 4357 pregnant reference women.
Information on major congenital anomalies is obtained from the Register of Congenital Malformations. The register includes information on all deliveries and terminations of pregnancy for fetal anomaly in Finland with at least one detected major congenital anomalies classified and coded according to the WHO International Classification of Diseases, 9th version (ICD-9).
The National Institute for Health and Welfare also maintains the Hospital Discharge Registry (HDR). We collected information on all hospitalizations during a time period from 10 months before the delivery until one month postpartum, including information on the number and duration of hospital in-patient episodes, as well as one main diagnosis and a maximum of two subsidiary diagnoses related to the hospital episode.
Key Message
Women with epilepsy are at an increased risk of complications and hospitalizations during pregnancy, and delivery, including induction of labor or a cesarean section. The risk of several perinatal health outcomes is increased among offspring of women with epilepsy. However, the majority of women with epilepsy have a normal pregnancy.
Information on pregnancy complications included hospital discharge diagnoses of gestational hypertension, preeclampsia, bleeding in early pregnancy, hyperemesis gravidarum, gestational diabetes, maternal care for fetal abnormality, polyhydramnios, oligohydramnios, placenta previa, placental abruption, pregnancy cholestasis, premature rupture of membranes (PROM) or premature contractions. Similarly, complications during childbirth included prolonged labor, fetal distress, bleeding during or after delivery, or puerperal sepsis. The diagnoses were classified according to the International Classification of Diseases, 9th (1987) (1988) (1989) (1990) (1991) (1992) (1993) (1994) (1995) or 10th version codes (from 1996 onwards).
Analyses were not performed on diagnoses with fewer than 10 cases among WWE and fewer than 20 cases in the reference group (maternal care for fetal abnormality, polyhydramnios, oligohydramnios, placenta previa and placental abruption).
Information on socioeconomic status (SES) was obtained from Statistics Finland. Practically all Finnish pregnant women (99.8%) give birth in a hospital (9) and information on out-of-hospital deliveries is also covered by the MBR since 1990. The HDR and the MBR thus contain information of all deliveries during the study period. Data from the registers was linked to each study subject based on the unique personal identification number assigned to all residents of Finland.
The statistical significance of the differences in maternal characteristics between WWE and the reference cohort was assessed with the Pearson's chi-squared test. Crude and adjusted risk ratios [crude relative risk (RR) and adjusted risk ratio (aRR)] with 95% confidence intervals (95% CI) were calculated by binomial regression with log link (except negative binomial regression for the number of in-hospital days) using STATA 12.1 (StataCorp, College Station, TX, USA). Statistical significance for the RRs was obtained by relating the change in deviance to the change in degrees of freedom in the chi-square distribution. Potential confounding factors were maternal age at delivery, calendar year of delivery, number of previous births and maternal SES. Effect modification was analyzed by means of the statistical significance of adding an interaction term into a regression model with the main effects. Improvement in goodness of fit (p < 0.05) by means of a likelihood ratio test between the nested models was used as the criterion. The RRs in the Results section were adjusted for age and calendar year of delivery, if not otherwise specified. Analyses on perinatal health outcomes were restricted to singleton livebirths.
Analyses of in-hospital days were carried out by negative binomial regression. In this model, crude and adjusted incidence rate ratios (IRR) with 95% CI were calculated.
The hospitalization data on maternal pregnancy-related diagnoses were analyzed using stepwise adjustments in the following models: (1) a crude analysis; (2) adjustment for maternal age at delivery and calendar year of delivery; (3) additional adjustment for parity and (4) additional adjustment for SES. The SES data were missing for 24.5% of women (26.1% for WWE and 23.9% for the reference cohort).
The study protocol was reviewed by the ethical committee of the Pirkanmaa Hospital District (tracking number R09251/2010). Register-based studies were conducted with the permission of the register holders. Because the study subjects were not contacted, informed consent was not required, in accordance with Finnish legislation. The personal identifiers were removed before analyses for protection of privacy.
Results
A total of 1737 WWE and 4357 women in the reference cohort had at least one delivery during the study period. The WWE were generally younger, more often primiparous, had more frequently a previous induced abortion or an ectopic pregnancy, and were of lower SES than the reference group (Table 1) .
Overall, 350 (20.2%) WWE had pregnancy complications compared with 688 (15.9%) women in the reference group (results not shown in table). The frequencies for delivery complications were comparable (16.4% vs. 16.6%). There was no increased risk of gestational or chronic hypertension, preeclampsia, bleeding in early pregnancy or hyperemesis gravidarum for WWE compared with the reference group (Table 2) . WWE, who had diabetes, had slightly more hospitalizations than women with diabetes in the reference group (4.2% vs. 3.2%), but the differences were not statistically significant in all models. There was no statistically significant increase in the incidence of gestational diabetes. Fewer WWE than women in the reference group (0.7% vs. 1.3%) were hospitalized for liver cholestasis in pregnancy (aRR 0.53, 95% CI 0.29-0.99).
Among WWE, 1.4% of women were diagnosed with an infection during pregnancy or postpartum compared with 0.4% in the reference group (aRR 3.15, 95% CI 1.72-5.76) ( Table 2 ). The frequency of injuries, poisonings and consequences of other external causes was higher among WWE than in the reference group (1.2% vs. 0.6%, crude RR 1.78, 95% CI 1.01-3.16). Although the risk was no longer statistically significant after adjustment for maternal age and calendar year of delivery, it remained significant after additional adjustments for parity and SES (aRR 1.81, 95% CI 1.02-3.22, aRR 2.04, 95% CI 1.04-3.98 respectively).
Of the delivery complications, PROM occurred in 2.0% of pregnant WWE compared with 1.1% of women in the reference group (aRR 1.75, 95% CI 1.14-2.69), but the difference was statistically significant after adjustment for parity and SES ( Table 2 ). The frequencies for premature contractions (before the 37th full gestational week) were 6.0% for WWE and 3.3% for the reference group (aRR 1.75, 95% CI 1.36-2.23). WWE had a slightly increased risk of induced delivery (aRR 1.24, 95% CI 1.09-1.41), and elective or emergency CS (aRR 1.28, 95% CI 1.14-1.44) ( Table 3 ). This led to WWE having fewer spontaneous deliveries compared with the women in the reference group. The incidences of live and stillbirths were comparable between the groups.
There was no difference in preterm deliveries between the groups, but the risk of being small for gestational age (SGA) was clearly increased in the offspring of WWE (aRR 1.57, 95% CI 1.23-2.01) (Table 3) . Furthermore, offspring of WWE had a clearly increased risk of respiratory care (aRR 2.37, 95% CI 1.57-3.60) and of admission to neonatal intensive care unit (aRR 1.66, 95% CI 1.39-1.97). Analyses restricted to children born in [1987] [1988] [1989] [1990] [1991] [1992] [1993] [1994] [1995] [1996] [1997] [1998] [1999] [2000] [2001] showed that offspring of WWE had a higher risk for major congenital anomalies (n = 79, 4.6%) compared with offspring of the reference group (n = 109, 2.5%, p < 0.001). Analyses on other pregnancy outcomes that including adjustment for major congenital anomalies showed an increased risk of respiratory care (aRR 2.13, 95% CI 1.41-3.24) among WWE.
WWE and the reference group had similar risks of prolonged labor and uterine inertia, fetal distress during delivery, bleeding during delivery or postpartum and puerperal sepsis (Table 4) .
Regarding hospitalizations, WWE had slightly more inhospital days for all causes combined compared with the women in the reference group (mean 6 days vs. 5 days, IRR 1.29, 95% CI 1.25-1.34) (results not shown in tables). The finding remained even when antepartum inhospital days (mean 4.67 vs. 3.10, IRR 1.51, 95% CI 1.42-1.60) and postpartum in-hospital days (mean 4.27 vs. 3.85, IRR 1.11, 95% CI 1.07-1.14) were analyzed separately. There was a clear increase in the number of in-hospital days because of premature contractions (mean 0.45 vs. 0.22, IRR 1.96, 95% CI 1.20-3.22).
Contrasting trends in risk of hospitalization for accidents were found. WWE had an increasing trend in risk with years since diagnosis, but the reference group had a decrease in risk with time since index date (p = 0.015 for interaction). We found no increase in incidence of hypertensive disorders among WWE. Earlier findings on hypertensive disorders among WWE during pregnancy have been conflicting (10-13). We observed a lower incidence of hospitalization for pregnancy cholestasis among WWE, though the absolute numbers were small (n = 12 among WWE vs. n = 15 in reference cohort). This appears to be a novel finding as we are unaware of such previous reports, and it requires confirmation. The finding could be attributed to the AED-induced increase in liver function.
Our results showed increased hospitalizations for premature contractions and PROM among WWE, but the risk was not statistically significant after adjustment for SES. Furthermore, there was no difference in premature delivery. Some previous studies have reported no difference in the incidence of PROM (12) (13) (14) (15) and no substantial increase in premature contractions for WWE (7) . Likewise, several studies have shown no increase in premature delivery overall for WWE (4, 11, 16, 17) . On the other hand, recent studies have suggested an increased risk of premature delivery limited to WWE using AED (3, 6, 8, 12) . Nonetheless, there are contradictory results suggesting a higher risk of premature delivery only for WWE without AED (18, 19) . Our finding of a slightly increased risk of preterm PROM in WWE may be related to the increased risk of infections (20) . However, the impact of PROM on the premature deliveries overall may be minimal, since preterm contractions are a poor indicator for premature delivery, despite their high frequency (21) .
We observed no increase in bleeding in early pregnancy, or during or after delivery in WWE. Previous research suggests a moderately increased risk of bleeding in late pregnancy, as well as during and after delivery for WWE (7) using AED (3, 6, (13) (14) (15) . In a hospital-based study, WWE had significantly more bleeding in early pregnancy (19) , whereas a population-based study showed no difference (13) . Some studies have reported no excess of these outcomes in WWE (4, 15, 16, 22) .
In our study, induction of delivery was more common in WWE. Similar results have been reported earlier for WWE, especially those on AED (3, 4, 19) . Our results showed no excess of assisted deliveries for WWE, which is consistent with previous findings (3, 13, 15) .
Our findings were consistent with previous studies indicating that WWE have a higher frequency of CS, especially among women with active epilepsy or on AED (7, (10) (11) (12) (13) (14) . A Finnish study reported a slightly increased rate of CS in WWE (17) . The increased CS and inductions of delivery might be attributed partly to WWE being treated as high-risk obstetric patients who are more likely referred for an elective CS or an induction than women without epilepsy, i.e. the differences may reflect mainly healthcare practices. The subjective perception of pregnancy-related problems may also be more common in WWE, thus leading to more frequent hospitalizations and obstetric interventions. However, we cannot exclude the possible involvement of fetal or other factors.
We found a clearly increased risk of SGA in offspring of WWE. A recent Finnish study reported no overall increase in SGA among offspring of WWE, but did show an excess limited to those on AED polytherapy during pregnancy (17) . As we did not have information on AED use, we could not assess its effect.
We found a clearly increased risk of respiratory care and admission to neonatal intensive care unit in offspring of WWE. These results were in line with a previous Finnish study based partly on the same data from the MBR (17) .
A recent Finnish study found that WWE more often smoked and had more co-morbidities than women without epilepsy. More than half (63%) of the offspring of WWE were exposed to AED during pregnancy (17) . In a population-based study, pregnant WWE smoked and had diabetes (type 1 and 2) more frequently than other women (3). We had no information on maternal smoking during pregnancy, but SES was used as a proxy for it. However, adjustment for SES did not affect the results substantially.
The overall validity in our study registers is good. An agreement of 98% of the HDR diagnoses of complications of pregnancy and childbirth has been found with the medical records (principal 95%, subsidiary diagnoses 78%) (23) . The positive predictive value of complications of pregnancy and childbirth was 94% in the HDR (24) .
With a register-based approach, we had comprehensive enrollment and comparable follow up with less ascertainment bias than hospital-based or questionnaire studies. Combining information from the MBR and the HDR enabled a comprehensive approach to assess complications during pregnancy, delivery and postpartum, and allowed the investigation of the most common complications, including outcomes rarely investigated previously.
More intensive medical follow up with more detailed recording, reporting and registration of complications during and after pregnancy may have affected the observed incidence of pregnancy and delivery complications, as well as adverse health outcomes in offspring of epilepsy patients. Hence, differences in reporting may have overestimated the incidence of complications in WWE and adverse health outcomes in their offspring in relation to women without epilepsy.
The prevalence of major congenital anomalies may increase the risk of other perinatal adverse health outcomes, such as SGA, and the need for respiratory care (25) . We did not have this information for the entire study population, but it was available for children born in 1987-2001. Our results showed a clearly higher frequency of major congenital anomalies in offspring of WWE. However, adjustment for congenital anomalies did not materially affect the results, except for a slight decrease in the need for respiratory care from 2.37 to 2.13.
A proportion of women in our patient cohort are likely in remission with AED that was discontinued before pregnancy. This would dilute any effect of active epilepsy. Patient groups with different types of epilepsy syndromes, severity of epilepsy, and AED may also differ in relation to other factors affecting pregnancy and childbearing. As we did not have information on detailed medical history, medical treatment during pregnancy including AEDs, type of AED, or type or severity of maternal epilepsy, the effect of epilepsy type and AED on pregnancy and delivery could not be evaluated in this study. Likewise, no detailed information on complications during earlier pregnancies and childbirths was available. Therefore, confounding by indication is possible, and the results of this study should be interpreted with caution.
Our study focused on hospital discharge diagnoses. Illnesses mainly treated in outpatient clinics and rarely in hospitals (for example gestational diabetes) might have been underreported. We did not differentiate between the main diagnosis and the subsidiary diagnoses of hospitalization. Therefore, it was not possible to specify whether the diagnosis in question caused extra hospitalizations or lengthening in the hospital stay, or whether it was a minor complication or a preexisting illness. Subsidiary diagnoses of WWE may be recorded more comprehensively than those of reference women, which could overestimate the risk among WWE.
Identification of patients with epilepsy from this database may have been incomplete. A proportion of women in our patient cohort are likely in remission with AED discontinued before pregnancy. This would dilute any effect of active epilepsy. Institutionalized patients were not included since their AED costs are not compensated through the Social Insurance Institution. Therefore, our results are generalizable for non-institutionalized WWE. Also, persons who have refused reimbursement are not included in the register. However, the cost of AED is high in Finland, and therefore few people with epilepsy refuse reimbursement.
Our results showing an increased risk of complications and hospitalizations during pregnancy have implications for obstetric practice regarding WWE. These results underscore the importance of intensive pregnancy follow up in WWE. WWE did not have an increased risk of complications during delivery or postpartum, but had more frequent CS and induction of delivery. Also, their offspring were more likely to be SGA, need respiratory care or be admitted to neonatal intensive care unit than were offspring of women without epilepsy. However, as we did not have information on AED use, or type of epilepsy, we were unable to address these outcomes separately among WWE on AED or with active epilepsy.
In summary, WWE have a slightly increased risk of pregnancy complications and hospitalizations during pregnancy and delivery, including induction of delivery or a CS. The risk of several perinatal health outcomes is increased among offspring of WWE, but the majority had normal pregnancies. The roles of AEDs and severity of epilepsy should be evaluated in future studies.
